Publication: Evaluating potentially inappropriate medications in the elderly with seven different screening tools
dc.contributor.author | Büyükuysal, Mustafa Çağatay | |
dc.contributor.buuauthor | DEMİRCAN, CELALEDDİN | |
dc.contributor.buuauthor | HASANZADE, ULVIYYA | |
dc.contributor.buuauthor | Hasanzade, Ulviyya | |
dc.contributor.buuauthor | Tatar, Mustafa | |
dc.contributor.buuauthor | TATAR, MUSTAFA | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı. | |
dc.contributor.researcherid | EXU-7466-2022 | |
dc.contributor.researcherid | JYD-8829-2024 | |
dc.contributor.researcherid | JYJ-6867-2024 | |
dc.date.accessioned | 2024-11-18T08:23:13Z | |
dc.date.available | 2024-11-18T08:23:13Z | |
dc.date.issued | 2023-01-01 | |
dc.description.abstract | Introduction: We aimed to determine the rates of potentially inappropriate medications using various screening tools and also the affecting factors in elderly patients.Materials and Method: In this prospective cross-sectional study, we recorded in detail the concomitant chronic diseases, geriatric syndromes, and drugs used in elderly patients admitted to a university hospital and then assessed potentially inappropriate medications using seven different screening tools.Results: The study included 315 patients (190 female; 125 male). We evaluated potentially inappropriate medication use with the PRISCUS, EU(7), Beers 2019, STOPP v2, and TIME-to-STOP criteria and evaluated potential prescription omissions with the START v2 and TIME-to-START criteria; the resulting identified rates of PIMs were 15.9%, 45.1%, 48.9%, 44.8%, 48.3%, 73.9%, and 97.5%, respectively. The lowest value was found with PRISCUS, as it uses fewer criteria than the others. The EU(7), Beers 2019, STOPP v2, and TIME-to -STOP results were similar to one another. START v2 and TIME-to-START yielded higher outcomes than the others due to the omission of vaccines in patients. The highest outcome was found with TIME-to-START due to the omission of the herpes zoster vaccine (97.5%), which appears only in that screening tool. Potentially inappropriate medication rates increased with the number of drugs used and with the number of concomitant chronic diseases.Conclusion: This study detected potentially inappropriate medication use in approximately half of the patients with the EU(7), Beers 2019, STOPP v2, and TIME-to-STOP screening tools. There was a positive correlation between potentially inappropriate medications and polypharmacy and increased disease burden. | |
dc.identifier.doi | 10.29400/tjgeri.2023.369 | |
dc.identifier.endpage | 423 | |
dc.identifier.issn | 1304-2947 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 413 | |
dc.identifier.uri | https://doi.org/10.29400/tjgeri.2023.369 | |
dc.identifier.uri | https://hdl.handle.net/11452/47981 | |
dc.identifier.volume | 26 | |
dc.identifier.wos | 001134752500007 | |
dc.indexed.wos | WOS.SCI | |
dc.indexed.wos | WOS.SSCI | |
dc.language.iso | en | |
dc.publisher | Turkish Geriatrics Soc | |
dc.relation.journal | Turkish Journal Of Geriatrics-turk Geriatri Dergisi | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Older-people | |
dc.subject | Stopp/start criteria | |
dc.subject | Eu(7)-pim list | |
dc.subject | Polypharmacy | |
dc.subject | Prevalence | |
dc.subject | Beers | |
dc.subject | Potentially inappropriate medication list | |
dc.subject | Polypharmacy | |
dc.subject | Aged | |
dc.subject | Science & technology | |
dc.subject | Life sciences & biomedicine | |
dc.subject | Geriatrics & gerontology | |
dc.subject | Gerontology | |
dc.subject | Geriatrics & gerontology | |
dc.title | Evaluating potentially inappropriate medications in the elderly with seven different screening tools | |
dc.type | Article | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 242ca593-b508-41f1-b6e4-a45dee33c95e | |
relation.isAuthorOfPublication | 9509978e-d295-4aa3-95a9-f3388914bbf4 | |
relation.isAuthorOfPublication.latestForDiscovery | 242ca593-b508-41f1-b6e4-a45dee33c95e |